Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $92.95 million. The enterprise value is $95.09 million.
Important Dates
The next estimated earnings date is Friday, December 27, 2024, before market open.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 102.46 million shares outstanding. The number of shares has decreased by -0.78% in one year.
| Shares Outstanding | 102.46M |
| Shares Change (YoY) | -0.78% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 38.40% |
| Owned by Institutions (%) | 0.92% |
| Float | 63.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 51.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.10.
| Current Ratio | 0.85 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,159.80 |
Financial Efficiency
Return on equity (ROE) is -181.23% and return on invested capital (ROIC) is -125.93%.
| Return on Equity (ROE) | -181.23% |
| Return on Assets (ROA) | -69.58% |
| Return on Capital (ROIC) | -125.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.53M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.96% in the last 52 weeks. The beta is 0.18, so TLSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +37.96% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 45.89 |
| Average Volume (20 Days) | 318,906 |
Short Selling Information
| Short Interest | 53,735 |
| Short Previous Month | 60,592 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.80M |
| Pretax Income | -17.24M |
| Net Income | -13.73M |
| EBITDA | -15.79M |
| EBIT | -15.80M |
| Earnings Per Share (EPS) | -$0.13 |
Full Income StatementBalance Sheet
The company has $1.13 million in cash and $179,000 in debt, giving a net cash position of $951,000 or $0.01 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | 179,000 |
| Net Cash | 951,000 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 1.86M |
| Book Value Per Share | 0.02 |
| Working Capital | -1.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.91 million and capital expenditures -$14,000, giving a free cash flow of -$3.92 million.
| Operating Cash Flow | -3.91M |
| Capital Expenditures | -14,000 |
| Free Cash Flow | -3.92M |
| FCF Per Share | -$0.04 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |